Anthony B Pinkerton

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. ncbi Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge
    Daniel S Lorrain
    Department of Neuropharmacology, Merck Research Laboratories, San Diego, CA 92121, USA
    Neuropsychopharmacology 28:1622-32. 2003
  2. ncbi Phenyl-tetrazolyl acetophenones: discovery of positive allosteric potentiatiors for the metabotropic glutamate 2 receptor
    Anthony B Pinkerton
    Merck Research Laboratories San Diego, 3535 General Atomics Court, San Diego, California 92121, USA
    J Med Chem 47:4595-9. 2004
  3. ncbi Stereocontrolled total synthesis of (+)-streptazolin by a palladium-catalyzed reductive diyne cyclization
    Barry M Trost
    Department of Chemistry, Stanford University, Stanford, CA 94305-5080, USA
    Angew Chem Int Ed Engl 43:4327-9. 2004
  4. ncbi Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 1: Identification and synthesis of phenyl-tetrazolyl acetophenones
    Anthony B Pinkerton
    Merck Research Laboratories, MRLSDB2, 3535 General Atomics Court, San Diego, CA 92121, USA
    Bioorg Med Chem Lett 14:5329-32. 2004
  5. ncbi 3-(2-Ethoxy-4-{4-[3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxy]butoxy}phenyl)propanoic acid: a brain penetrant allosteric potentiator at the metabotropic glutamate receptor 2 (mGluR2)
    Rowena V Cube
    Department of Chemistry, Merck Research Laboratories, MRLSDB2, 3535 General Atomics Court, San Diego, CA 92121, USA
    Bioorg Med Chem Lett 15:2389-93. 2005
  6. ncbi Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 2: 4-thiopyridyl acetophenones as non-tetrazole containing mGlu2 receptor potentiators
    Anthony B Pinkerton
    Merck Research Laboratories, MRLSDB2, 3535 General Atomics Court, San Diego, CA 92121, USA
    Bioorg Med Chem Lett 14:5867-72. 2004
  7. ncbi Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 3: Identification and biological activity of indanone containing mGlu2 receptor potentiators
    Anthony B Pinkerton
    Merck Research Laboratories, MRLSDB2, 3535 General Atomics Court, San Diego, CA 92121, USA
    Bioorg Med Chem Lett 15:1565-71. 2005
  8. ncbi Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2
    Herve Schaffhauser
    Merck Research Laboratories, 3535 General Atomics Court, San Diego CA 92121, USA
    Mol Pharmacol 64:798-810. 2003
  9. ncbi Pyrimidine methyl anilines: selective potentiators for the metabotropic glutamate 2 receptor
    Essa Hu
    Department of Medicinal Chemistry, Merck Research Laboratories, San Diego, CA 92121, USA
    Bioorg Med Chem Lett 14:5071-4. 2004
  10. ncbi Diaryl substituted pyrazoles as potent CCR2 receptor antagonists
    Anthony B Pinkerton
    Department of Medicinal Chemistry, Merck Research Laboratories, MRLSDB2, 3535 General Atomics Court, San Diego, CA 92121, USA
    Bioorg Med Chem Lett 17:807-13. 2007

Collaborators

Detail Information

Publications12

  1. ncbi Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge
    Daniel S Lorrain
    Department of Neuropharmacology, Merck Research Laboratories, San Diego, CA 92121, USA
    Neuropsychopharmacology 28:1622-32. 2003
    ....
  2. ncbi Phenyl-tetrazolyl acetophenones: discovery of positive allosteric potentiatiors for the metabotropic glutamate 2 receptor
    Anthony B Pinkerton
    Merck Research Laboratories San Diego, 3535 General Atomics Court, San Diego, California 92121, USA
    J Med Chem 47:4595-9. 2004
    ..This represents the first example of the efficacy of mGlu2 receptor potentiators in these models...
  3. ncbi Stereocontrolled total synthesis of (+)-streptazolin by a palladium-catalyzed reductive diyne cyclization
    Barry M Trost
    Department of Chemistry, Stanford University, Stanford, CA 94305-5080, USA
    Angew Chem Int Ed Engl 43:4327-9. 2004
  4. ncbi Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 1: Identification and synthesis of phenyl-tetrazolyl acetophenones
    Anthony B Pinkerton
    Merck Research Laboratories, MRLSDB2, 3535 General Atomics Court, San Diego, CA 92121, USA
    Bioorg Med Chem Lett 14:5329-32. 2004
    ..Structure activity relationship studies directed toward improving the potency and level of potentiation led to the discovery of 22 (EC(50)=93nM, 128% potentiation)...
  5. ncbi 3-(2-Ethoxy-4-{4-[3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxy]butoxy}phenyl)propanoic acid: a brain penetrant allosteric potentiator at the metabotropic glutamate receptor 2 (mGluR2)
    Rowena V Cube
    Department of Chemistry, Merck Research Laboratories, MRLSDB2, 3535 General Atomics Court, San Diego, CA 92121, USA
    Bioorg Med Chem Lett 15:2389-93. 2005
    ..p., brain level of 5700 nM)...
  6. ncbi Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 2: 4-thiopyridyl acetophenones as non-tetrazole containing mGlu2 receptor potentiators
    Anthony B Pinkerton
    Merck Research Laboratories, MRLSDB2, 3535 General Atomics Court, San Diego, CA 92121, USA
    Bioorg Med Chem Lett 14:5867-72. 2004
    ..Structure-activity relationship studies directed toward replacement of the tetrazole in the initial lead led to the discovery of 16 (EC(50)=340 nM), which showed improved brain penetration over the initial lead...
  7. ncbi Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 3: Identification and biological activity of indanone containing mGlu2 receptor potentiators
    Anthony B Pinkerton
    Merck Research Laboratories, MRLSDB2, 3535 General Atomics Court, San Diego, CA 92121, USA
    Bioorg Med Chem Lett 15:1565-71. 2005
    ..Structure activity relationship studies directed toward improving the potency and level of potentiation, as well as PK properties, led to the discovery of 28 (EC50=186 nM), which displayed activity in a rodent model for schizophrenia...
  8. ncbi Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2
    Herve Schaffhauser
    Merck Research Laboratories, 3535 General Atomics Court, San Diego CA 92121, USA
    Mol Pharmacol 64:798-810. 2003
    ..We propose that this allosteric binding site defines a pocket that is different from the orthosteric site located in the amino terminal domain...
  9. ncbi Pyrimidine methyl anilines: selective potentiators for the metabotropic glutamate 2 receptor
    Essa Hu
    Department of Medicinal Chemistry, Merck Research Laboratories, San Diego, CA 92121, USA
    Bioorg Med Chem Lett 14:5071-4. 2004
    ..Pyrimidine methyl anilines as potent and selective mGlu2 potentiators are described. Findings from the structure-activity-relationship investigations are discussed...
  10. ncbi Diaryl substituted pyrazoles as potent CCR2 receptor antagonists
    Anthony B Pinkerton
    Department of Medicinal Chemistry, Merck Research Laboratories, MRLSDB2, 3535 General Atomics Court, San Diego, CA 92121, USA
    Bioorg Med Chem Lett 17:807-13. 2007
    ..Structure-activity relationship studies directed toward improving the potency led to the discovery of 23 (IC50 = 6 nM)...
  11. ncbi Synthesis and SAR of thiophene containing kinesin spindle protein (KSP) inhibitors
    Anthony B Pinkerton
    Department of Medicinal Chemistry, Kalypsys, Inc, 10420 Wateridge Circle, San Diego, CA 92121, USA
    Bioorg Med Chem Lett 17:3562-9. 2007
    ..SAR studies led to the synthesis of 33, which was co-crystallized with KSP and determined to bind to an allosteric pocket previously described for other known KSP inhibitors...
  12. ncbi A synthesis of trisubstituted alkenes by a Ru-catalyzed addition
    Barry M Trost
    Department of Chemistry, Stanford University Stanford, CA 94305 5080, USA
    Chemistry 8:2341-9. 2002
    ..The first C-C bond formation generally involves sterically less hindered carbons of the alkenes and alkynes. Modest to very high regioselectivity can be achieved depending on the steric difference of the two substituents of alkynes...